The global medical industry experienced a 15% decline in the number of remote patient monitoring-related patent applications in Q3 2023 compared with the previous quarter. The total number of remote patient monitoring-related grants dropped by 4% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of remote patient monitoring-related patent applications in the medical industry was 2,775 in Q3 2023, versus 3,255 in the prior quarter.
The top five companies accounted for 10% of patenting activity
Analysis of patenting activity by companies shows that Johnson & Johnson filed the most remote patient monitoring patents within the medical industry in Q3 2023. The company filed 79 remote patient monitoring-related patents in the quarter, compared with 72 in the previous quarter. It was followed by Medtronic with 70 remote patient monitoring patent filings, DexCom (52 filings), and Abbott Laboratories (42 filings) in Q3 2023.
Patenting activity was driven by the US with a 30% share of total patent filings
The largest share of remote patient monitoring related patent filings in the medical industry in Q3 2023 was in the US with 30%, followed by China (20%) and South Korea (9%). The share represented by the US was 2% lower than the 31% share it accounted for in Q2 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2023, buy the databook here.